Scientists urge caution on antibiotic alternatives

January 22, 2014, University of Liverpool
Scientists urge caution on antibiotic alternatives
The new treatments are intended to enable the patient to tolerate disease, and buy the immune system valuable time to get rid of the infection naturally

New types of drugs intended for use in place of antibiotics have been given a cautious welcome by scientists at the Universities of Liverpool and Edinburgh.

Researchers have been probing the long-term effectiveness of drugs being developed by the . These work by limiting the symptoms caused by a bug or virus in the body, rather than killing it outright.

Becoming resistant

These treatments are designed to avoid the problem of infections becoming resistant to treatment, which has become widespread with antibiotics.

This approach is intended to enable the patient to tolerate , and buy the immune system valuable time to get rid of the infection naturally.

Researchers at the Universities of Liverpool and Edinburgh created a to discover how drugs that limit the damage caused by disease could affect how infections spread and evolve.
They found that for infections where the symptoms are not linked to the spread of disease, these drugs may prevent disease from evolving too quickly. They will be useful over longer periods of time.

However, parasitologist, Dr Andy Fenton, from Liverpool's Institute of Integrative Biology cautions that people given damage limitation treatments may appear healthy, but carry high levels of infection and so may be more likely to pass on disease. In addition, people with lesser symptoms could remain undiagnosed and add to the spread of disease.

Cautious

"Antibiotic resistance is a serious issue and these alternatives offer hope in solving the problem," he said.

"However we should be cautious as it's possible that in some cases these drugs may cause disease to spread."

Explore further: CDC addresses burden, threat of antibiotic resistance

More information: "Limiting Damage during Infection: Lessons from Infection Tolerance for Novel Therapeutics." Pedro F. Vale, Andy Fenton, Sam P. Brown. PLOS Biology. Published: January 21, 2014. DOI: 10.1371/journal.pbio.1001769

Related Stories

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

A world without antibiotics? The risk is real, experts say

January 19, 2014
Humans face the very real risk of a future without antibiotics, a world of plummeting life expectancy where people die from diseases easily treatable today, scientists say.

How UTIs in women may damage kidneys

November 8, 2013
A scientist from the Institute of Translational Medicine has been awarded a £190,000 Fellowship by Kidney Research UK to investigate how the E.coli bacteria which cause Urinary Tract Infections (UTIs) move to the kidneys ...

FDA's voluntary antibiotics guidelines fail to protect public health

December 12, 2013
Experts at the Johns Hopkins Center for a Livable Future (CLF), say that new Food and Drug Administration (FDA) voluntary guidelines on antibiotic use in food animal production are unlikely to reduce the widespread use of ...

Getting better without antibiotics

May 30, 2013
Given the option, many women with symptoms of urinary tract infections are choosing to avoid antibiotics and give their bodies a chance to heal naturally, finds research in BioMed Central's open access journal BMC Family ...

Silencing signals sent by parasite could aid sleeping sickness fight

December 15, 2013
A new discovery by scientists could help combat the spread of sleeping sickness.

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.